type-2-diabetes-mellitus

Documents about type-2-diabetes-mellitus

• Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes#238274ClinicalTrials.gov
• Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes#272309ClinicalTrials.gov
• Weight Off-loading Training, Cardiovascular Indices, Diabetes#261427ClinicalTrials.gov
• 20 Years Results by HBP and DBP in Patients With Type 2 Diabetes Mellitus After Following-up#121502ClinicalTrials.gov
• Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus#184805ClinicalTrials.gov
• Time-Restricted Eating for Type II Diabetes: TRE-T2D#180319ClinicalTrials.gov
• A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)#175086ClinicalTrials.gov
• Effect of Diabetes Self-management Education and Support on Glycemic Control Among Patients With Type 2 Diabetic#18815ClinicalTrials.gov
• Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects#127826ClinicalTrials.gov
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy#136225ClinicalTrials.gov
• Non-inteRvEntional Study to Observe rAtionaLe to Select add-on TherapY for Type 2 Diabetes Inadequately Controlled With Metformin.#140956ClinicalTrials.gov
• Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin#154879ClinicalTrials.gov
• A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes#162412ClinicalTrials.gov
• Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients#172523ClinicalTrials.gov
• Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes Mellitus#175093ClinicalTrials.gov
• Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes#181699ClinicalTrials.gov
• Efficacy of Continuous Subcutaneous Insulin Infusion Versus Basal-bolus Multiple Daily Injections Regimen in Type 2 Diabetes#195519ClinicalTrials.gov
• Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects#201735ClinicalTrials.gov
• A Rural OPTIFAST Intervention for Partial Remission of Type 2 Diabetes in Adults With Obesity#217194ClinicalTrials.gov
• Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes Mellitus#230378ClinicalTrials.gov
• A Study to Investigate the Benefits of the Early Detection and Intensive Treatment of Type 2 Diabetes#253179ClinicalTrials.gov
• Exercise Study on Cardiac Function in Patients With Diabetes Mellitus Type 2 and Diastolic Dysfunction#272281ClinicalTrials.gov
• Metformin for the Treatment of Diabetes in Pregnancy#154878ClinicalTrials.gov
• Scripps Digital Diabetes: Cloud-Based Continuous Glucose Monitoring (CB CGM)#257068ClinicalTrials.gov
• Add Glucokinase Activator to Target A1c#121271ClinicalTrials.gov
• Weight Loss Clinical Decision Support#136230ClinicalTrials.gov
• The Acute Effect of Interval-walking#141190ClinicalTrials.gov
• Glycemia in Diabetic Elders Trial#143785ClinicalTrials.gov
• Empa PASS on Urinary Tract Malignancies#146344ClinicalTrials.gov
• Korean Post-marketing Surveillance for Kombiglyze XR®#152384ClinicalTrials.gov
• US Inhaled Insulin Therapeutic Choice Questionnaire Study#201703ClinicalTrials.gov
• Detection of Ischemia in Asymptomatic Diabetics#208368ClinicalTrials.gov
• Investigational Study of Delayed Release Metformin#252960ClinicalTrials.gov
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control#28577ClinicalTrials.gov
• Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007)#127726ClinicalTrials.gov
• To Evaluate the Efficacy and Safety of JT-001 add-on in Paatients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin#158164ClinicalTrials.gov
• Empowering Primary Care Providers and Patients to Improve Chronic Disease Outcomes: The EMPOWER Participatory Action Research (EMPOWER - PAR)#226119ClinicalTrials.gov
• Chronic Effects of Two Aerobic-training Models Performed in Water and on Dry Land in Patients With Type 2 Diabetes Mellitus (T2DM).#234558ClinicalTrials.gov
• 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes#121281ClinicalTrials.gov
• Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus#127764ClinicalTrials.gov
• A Two Part Study of Peroral Insulin in Type 2 Diabetes#146426ClinicalTrials.gov
• Finding the Patient's Voice Diabetes Prevention Programs#180308ClinicalTrials.gov
• Diabetes Resistance Training Adaptations in Elderly#226176ClinicalTrials.gov
• Diabetes in India Nutrition Guidelines Study (DINGS)#257026ClinicalTrials.gov
• Percutaneous Electric Neurostimulation of Dermatome T7 Improves Glycemic Profile in Obese and Typo 2 Diabetic Patients#267943ClinicalTrials.gov
• A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 Diabetes#127829ClinicalTrials.gov
• Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin Treatment#146403ClinicalTrials.gov
• Collection of Blood for Gene Expression/Genomic Studies in Individuals With Diabetes (Qatar)#158128ClinicalTrials.gov
• A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active Comparator#18778ClinicalTrials.gov
• Relationship Between Red Cell Distribution Width (RDW) and HbA1C in Patients With Type 2 Diabetes Mellitus After Glycemic Control#67784ClinicalTrials.gov